| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:733336 | 6480464 | epigallocatechin gallate results in decreased expression of G6PC mRNA | CTD | PMID:15549673 |
| (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of G6PC mRNA | CTD | PMID:16988119 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of G6PC mRNA | CTD | PMID:18289764 |
| 17beta-estradiol | decreases expression | ISO | RGD:736011 | 6480464 | Estradiol results in decreased expression of G6PC mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | decreases expression | ISO | RGD:736011 | 6480464 | Estradiol results in decreased expression of G6PC mRNA | CTD | PMID:20106945 PMID:21632981 |
| 1H-pyrazole | decreases expression | ISO | RGD:733336 | 6480464 | pyrazole results in decreased expression of G6PC mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736011 | 6480464 | Tetrachlorodibenzodioxin affects the expression of G6PC mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733336 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of G6PC mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:736011 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of G6PC mRNA | CTD | PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of G6PC mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733336 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of G6PC mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733336 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of G6PC mRNA | CTD | PMID:18163543 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733336 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of G6PC mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733336 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of G6PC mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733336 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of G6PC mRNA | CTD | PMID:18163543 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of G6PC mRNA | CTD | PMID:18178546 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733336 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of G6PC mRNA | CTD | PMID:18172886 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733336 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of G6PC mRNA | CTD | PMID:18163543 PMID:17949056 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of G6PC mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of G6PC mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of G6PC protein]; more ... | CTD | PMID:15554553 |
| 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of G6PC mRNA | CTD | PMID:18289764 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:733336 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of G6PC mRNA | CTD | PMID:18648102 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | decreases expression | EXP | | 6480464 | AICA ribonucleotide results in decreased expression of G6PC mRNA | CTD | PMID:19664596 |
| aflatoxin B1 | affects expression | ISO | RGD:736011 | 6480464 | Aflatoxin B1 affects the expression of G6PC protein | CTD | PMID:20106945 |
| aluminium phosphide | increases activity | EXP | | 6480464 | aluminum phosphide results in increased activity of G6PC protein | CTD | PMID:20929055 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of G6PC mRNA | CTD | PMID:16483693 |
| anthracen-2-amine | increases expression | EXP | | 6480464 | 2-anthramine results in increased expression of G6PC mRNA | CTD | PMID:23038007 |
| bacitracin | decreases expression | EXP | | 6480464 | Bacitracin results in decreased expression of G6PC mRNA | CTD | PMID:18289764 |
| benzene | decreases expression | EXP | | 6480464 | Benzene results in decreased expression of G6PC mRNA | CTD | PMID:15878777 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733336 | 6480464 | Benzo(a)pyrene results in decreased expression of G6PC mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:736011 | 6480464 | Benzo(a)pyrene results in increased expression of G6PC mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | affects expression | ISO | RGD:736011 | 6480464 | Benzo(a)pyrene affects the expression of G6PC mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:733336 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of G6PC mRNA | CTD | PMID:21715664 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:733336 | 6480464 | Diethylhexyl Phthalate results in decreased expression of G6PC mRNA | CTD | PMID:19245819 |
| bisphenol A | increases expression | ISO | RGD:733336 | 6480464 | bisphenol A results in increased expression of G6PC protein; more ... | CTD | PMID:21932408 |
| bucladesine | increases expression | ISO | RGD:733336 | 6480464 | Bucladesine results in increased expression of G6PC mRNA | CTD | PMID:22859313 |
| bucladesine | multiple interactions | ISO | RGD:733336 | 6480464 | NFE2L2 gene mutant form promotes the reaction [Bucladesine results in increased expression of G6PC mRNA] | CTD | PMID:22859313 |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of G6PC mRNA | CTD | PMID:17327699 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of G6PC mRNA | CTD | PMID:17327699 |
| cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of G6PC mRNA | CTD | PMID:22110744 |
| cadmium sulfate | decreases expression | ISO | RGD:733336 | 6480464 | cadmium sulfate results in decreased expression of G6PC mRNA | CTD | PMID:16221973 |
| calcium atom | affects expression | EXP | | 6480464 | Calcium affects the expression of G6PC mRNA | CTD | PMID:15913539 |
| calcium(0) | affects expression | EXP | | 6480464 | Calcium affects the expression of G6PC mRNA | CTD | PMID:15913539 |
| carbamazepine | decreases expression | EXP | | 6480464 | Carbamazepine results in decreased expression of G6PC mRNA | CTD | PMID:17381134 |
| cefaloridine | decreases expression | EXP | | 6480464 | Cephaloridine results in decreased expression of G6PC mRNA | CTD | PMID:18500788 |
| choline | multiple interactions | ISO | RGD:733336 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of G6PC mRNA | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:733336 | 6480464 | Ciguatoxins affects the expression of G6PC mRNA | CTD | PMID:18353800 |
| cis-ketoconazole | affects expression | EXP | | 6480464 | Ketoconazole affects the expression of G6PC mRNA | CTD | PMID:18289764 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of G6PC mRNA | CTD | PMID:18289764 |
| clofibrate | multiple interactions | ISO | RGD:733336 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of G6PC mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of G6PC mRNA | CTD | PMID:12851107 |
| clofibrate | decreases expression | ISO | RGD:733336 | 6480464 | Clofibrate results in decreased expression of G6PC mRNA | CTD | PMID:17585979 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of G6PC mRNA | CTD | PMID:22465980 |
| copper atom | decreases expression | ISO | RGD:736011 | 6480464 | Copper results in decreased expression of G6PC mRNA | CTD | PMID:20875833 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of G6PC mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | ISO | RGD:736011 | 6480464 | Copper results in decreased expression of G6PC mRNA | CTD | PMID:20875833 |
| copper(2+) sulfate | decreases expression | ISO | RGD:736011 | 6480464 | Copper Sulfate results in decreased expression of G6PC mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | ISO | RGD:736011 | 6480464 | Cyclosporine results in decreased expression of G6PC mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:733336 | 6480464 | Cyclosporine results in decreased expression of G6PC mRNA | CTD | PMID:19770486 |
| D-glucose | multiple interactions | ISO | RGD:736011 | 6480464 | Glucose promotes the reaction [[ARNT protein binds to G6PC promoter] which results in increased expression of G6PC mRNA]; more ... | CTD | PMID:15767253 |
| D-glucose | multiple interactions | ISO | RGD:736011 | 6480464 | Glucose promotes the reaction [[ARNT protein binds to G6PC promoter] which results in increased expression of G6PC mRNA] | CTD | PMID:15767253 PMID:15767253 |
| D-glucose | multiple interactions | EXP | | 6480464 | tungstate inhibits the reaction [Glucose results in increased activity of G6PC protein]; more ... | CTD | PMID:16920846 |
| D-glucose | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [Glucose results in increased expression of G6PC mRNA] | CTD | PMID:19576170 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of G6PC mRNA | CTD | PMID:19576170 |
| D-glucose | increases activity | EXP | | 6480464 | Glucose results in increased activity of G6PC protein | CTD | PMID:16920846 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of G6PC mRNA | CTD | PMID:14988444 |
| dehydroepiandrosterone | decreases expression | ISO | RGD:733336 | 6480464 | Dehydroepiandrosterone results in decreased expression of G6PC mRNA | CTD | PMID:11228057 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with Forskolin] results in increased expression of G6PC mRNA; more ... | CTD | PMID:18972406 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of G6PC protein | CTD | PMID:15965953 PMID:23166830 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of G6PC mRNA | CTD | PMID:18972406 PMID:23166830 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of G6PC protein | CTD | PMID:15965953 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of G6PC mRNA | CTD | PMID:18972406 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of G6PC mRNA | CTD | PMID:15353170 PMID:17920746 |
| ethanol | decreases expression | ISO | RGD:733336 | 6480464 | Ethanol results in decreased expression of G6PC mRNA | CTD | PMID:19167417 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of G6PC mRNA | CTD | PMID:17920746 PMID:15353170 |
| felbamate | decreases expression | EXP | | 6480464 | felbamate results in decreased expression of G6PC mRNA | CTD | PMID:17381134 |
| folic acid | multiple interactions | ISO | RGD:733336 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of G6PC mRNA | CTD | PMID:20938992 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of G6PC mRNA | CTD | PMID:16920846 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of G6PC mRNA | CTD | PMID:14988444 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of G6PC mRNA | CTD | PMID:18556366 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of G6PC mRNA | CTD | PMID:15150374 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of G6PC mRNA | CTD | PMID:18346472 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of G6PC mRNA | CTD | PMID:18556366 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of G6PC mRNA | CTD | PMID:19196556 more ... |
| fructose | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of G6PC mRNA]; more ... | CTD | PMID:19196556 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of G6PC protein | CTD | PMID:19196556 |
| fumonisin B1 | decreases expression | ISO | RGD:733336 | 6480464 | fumonisin B1 results in decreased expression of G6PC mRNA | CTD | PMID:16221962 |
| gabapentin | decreases expression | EXP | | 6480464 | gabapentin results in decreased expression of G6PC mRNA | CTD | PMID:17381134 |
| glucose | multiple interactions | ISO | RGD:736011 | 6480464 | Glucose promotes the reaction [[ARNT protein binds to G6PC promoter] which results in increased expression of G6PC mRNA]; more ... | CTD | PMID:15767253 |
| glucose | multiple interactions | ISO | RGD:736011 | 6480464 | Glucose promotes the reaction [[ARNT protein binds to G6PC promoter] which results in increased expression of G6PC mRNA] | CTD | PMID:15767253 PMID:15767253 |
| glucose | multiple interactions | EXP | | 6480464 | tungstate inhibits the reaction [Glucose results in increased activity of G6PC protein]; more ... | CTD | PMID:16920846 |
| glucose | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [Glucose results in increased expression of G6PC mRNA] | CTD | PMID:19576170 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of G6PC mRNA | CTD | PMID:19576170 |
| glucose | increases activity | EXP | | 6480464 | Glucose results in increased activity of G6PC protein | CTD | PMID:16920846 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of G6PC mRNA | CTD | PMID:14988444 |
| heptadecafluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of G6PC mRNA | CTD | PMID:22387981 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of G6PC mRNA | CTD | PMID:22129741 |
| iron atom | decreases expression | EXP | | 6480464 | Iron deficiency results in decreased expression of G6PC mRNA | CTD | PMID:16629162 |
| L-methionine | multiple interactions | ISO | RGD:733336 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of G6PC mRNA | CTD | PMID:20938992 |
| lamivudine | multiple interactions | ISO | RGD:733336 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of G6PC mRNA | CTD | PMID:16931933 |
| metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [Glucose results in increased expression of G6PC mRNA] | CTD | PMID:19576170 |
| metformin | decreases expression | EXP | | 6480464 | Metformin results in decreased expression of G6PC mRNA | CTD | PMID:19664596 |
| metformin | decreases expression | ISO | RGD:733336 | 6480464 | Metformin results in decreased expression of G6PC mRNA | CTD | PMID:19664596 |
| microcystin-LR | decreases expression | ISO | RGD:733336 | 6480464 | cyanoginosin LR results in decreased expression of G6PC mRNA | CTD | PMID:17654400 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of G6PC mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:733336 | 6480464 | Diethylnitrosamine results in increased expression of G6PC mRNA | CTD | PMID:17942915 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of G6PC mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of G6PC protein]; more ... | CTD | PMID:15554553 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:733336 | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of G6PC mRNA] | CTD | PMID:17942915 |
| nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of G6PC mRNA | CTD | PMID:22110744 |
| nicotinamide | multiple interactions | ISO | RGD:733336 | 6480464 | Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of G6PC mRNA] | CTD | PMID:16917544 |
| ozone | decreases expression | ISO | RGD:733336 | 6480464 | Ozone results in decreased expression of G6PC mRNA | CTD | PMID:16183385 |
| paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel results in increased expression of G6PC mRNA | CTD | PMID:15585946 |
| paracetamol | multiple interactions | ISO | RGD:733336 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of G6PC mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | affects expression | ISO | RGD:733336 | 6480464 | Acetaminophen affects the expression of G6PC mRNA | CTD | PMID:15606129 PMID:17562736 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of G6PC mRNA | CTD | PMID:15084756 |
| paracetamol | affects expression | ISO | RGD:733336 | 6480464 | Acetaminophen affects the expression of G6PC mRNA | CTD | PMID:17562736 PMID:15606129 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of G6PC mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of G6PC mRNA | CTD | PMID:19162173 |
| phenobarbital | multiple interactions | ISO | RGD:733336 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of G6PC mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:736011 | 6480464 | Phenobarbital affects the expression of G6PC mRNA | CTD | PMID:19084549 |
| phenobarbital | decreases expression | ISO | RGD:733336 | 6480464 | Phenobarbital results in decreased expression of G6PC mRNA | CTD | PMID:19482888 PMID:19270015 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of G6PC mRNA | CTD | PMID:17381134 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of G6PC mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | ISO | RGD:733336 | 6480464 | Phenobarbital results in decreased expression of G6PC mRNA | CTD | PMID:19270015 PMID:19482888 |
| phenytoin | decreases expression | EXP | | 6480464 | Phenytoin results in decreased expression of G6PC mRNA | CTD | PMID:17381134 |
| phlorizin | multiple interactions | EXP | | 6480464 | Phlorhizin inhibits the reaction [Streptozocin results in increased expression of G6PC mRNA] | CTD | PMID:12446591 |
| pirinixic acid | increases expression | ISO | RGD:733336 | 6480464 | pirinixic acid results in increased expression of G6PC mRNA | CTD | PMID:17426115 PMID:18445702 |
| pirinixic acid | increases expression | ISO | RGD:733336 | 6480464 | pirinixic acid results in increased expression of G6PC mRNA | CTD | PMID:18445702 PMID:17426115 |
| plumbagin | multiple interactions | EXP | | 6480464 | plumbagin inhibits the reaction [Streptozocin results in increased activity of G6PC protein] | CTD | PMID:22960630 |
| pregnenolone 16alpha-carbonitrile | affects expression | EXP | | 6480464 | Pregnenolone Carbonitrile affects the expression of G6PC mRNA | CTD | PMID:19162173 |
| quercetin | decreases expression | ISO | RGD:736011 | 6480464 | Quercetin results in decreased expression of G6PC mRNA | CTD | PMID:21632981 |
| quinolin-8-ol | increases expression | ISO | RGD:736011 | 6480464 | Oxyquinoline results in increased expression of G6PC mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:733336 | 6480464 | resveratrol promotes the reaction [FOXO1 protein results in increased expression of G6PC mRNA] | CTD | PMID:16917544 |
| resveratrol | multiple interactions | EXP | | 6480464 | FOXO1 protein affects the reaction [resveratrol results in increased expression of G6PC mRNA] | CTD | PMID:15788402 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of G6PC mRNA]; more ... | CTD | PMID:19196556 |
| rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of G6PC mRNA | CTD | PMID:19664596 |
| sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of G6PC mRNA | CTD | PMID:22110744 |
| streptozocin | multiple interactions | EXP | | 6480464 | bis(maltolato)oxovanadium(IV) inhibits the reaction [Streptozocin results in increased expression of G6PC mRNA]; more ... | CTD | PMID:12446591 |
| streptozocin | multiple interactions | EXP | | 6480464 | plumbagin inhibits the reaction [Streptozocin results in increased activity of G6PC protein] | CTD | PMID:22960630 |
| streptozocin | increases activity | EXP | | 6480464 | Streptozocin results in increased activity of G6PC protein | CTD | PMID:22960630 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of G6PC mRNA | CTD | PMID:12446591 |
| sucrose | increases expression | EXP | | 6480464 | Sucrose results in increased expression of G6PC mRNA | CTD | PMID:12514263 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of G6PC mRNA | CTD | PMID:16239168 PMID:15963342 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of G6PC mRNA | CTD | PMID:15963342 PMID:16239168 |
| trans-resveratrol | multiple interactions | ISO | RGD:733336 | 6480464 | resveratrol promotes the reaction [FOXO1 protein results in increased expression of G6PC mRNA] | CTD | PMID:16917544 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | FOXO1 protein affects the reaction [resveratrol results in increased expression of G6PC mRNA] | CTD | PMID:15788402 |
| troglitazone | decreases expression | ISO | RGD:733336 | 6480464 | troglitazone results in decreased expression of G6PC mRNA | CTD | PMID:11228057 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of G6PC mRNA | CTD | PMID:10446394 |
| tunicamycin | decreases expression | ISO | RGD:733336 | 6480464 | Tunicamycin results in decreased expression of G6PC mRNA | CTD | PMID:17127020 |
| valproic acid | affects expression | ISO | RGD:733336 | 6480464 | Valproic Acid affects the expression of G6PC mRNA | CTD | PMID:17292431 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of G6PC mRNA | CTD | PMID:17381134 |
| valproic acid | decreases expression | ISO | RGD:733336 | 6480464 | Valproic Acid results in decreased expression of G6PC mRNA | CTD | PMID:17963808 |
| vancomycin | increases expression | ISO | RGD:733336 | 6480464 | Vancomycin results in increased expression of G6PC mRNA | CTD | PMID:18930951 |
| vancomycin | decreases expression | EXP | | 6480464 | Vancomycin results in decreased expression of G6PC mRNA | CTD | PMID:18289764 |
| zidovudine | multiple interactions | ISO | RGD:733336 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of G6PC mRNA | CTD | PMID:16931933 |